MedTrace Logo

Uterine Artery Occlusion for Fibroid Related Bleeding

NCT00496067 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 91

Last updated 2011-03-09

No results posted yet for this study

Summary

The primary objective of this study is to evaluate the safety and effectiveness of Doppler guided Uterine Artery Occlusion (D-UAO) as treatment for the reduction of fibroid-associated symptoms.

Conditions

  • Menorrhagia
  • Uterine Fibroids

Interventions

DEVICE

Doppler-Guided Uterine Artery Occlusion Device

For bilateral occlusion of the uterine arteries

Sponsors & Collaborators

  • Ethicon, Inc.

    lead INDUSTRY

Principal Investigators

  • David Robinson, MD · Ethicon, Inc.

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
25 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-04-30
Primary Completion
2009-12-31
Completion
2009-12-31

Countries

  • Denmark
  • France
  • Germany
  • Netherlands
  • Norway
  • Switzerland
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00496067 on ClinicalTrials.gov